Areas of Focus
- Tumor Pathogenesis
- Tumor Drug Resistance
- Tumor Translational Medicine
Academic Background & Achievements
- PhD: Southern Medical University
- Guangdong Province Special Support Plan 'Young Top-notch Talent in Scientific and Technological Innovation'
- Guangdong Province Outstanding Young Teacher in Higher Education
Publications
- HBX-induced miR-5188 impairs FOXO1 to stimulate β-catenin nuclear translocation and promotes tumor stemness in hepatocellular carcinoma., Lin X, Zuo S, Luo R, Li Y, Yu G, Zou Y, Zhou Y, Liu Z, Liu Y, Hu Y, Xie Y, Fang W, Liu Z*., 2019
- miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin., Y Zhen, W Fang, M Zhao, R Luo, Y Liu, Q Fu, Y Chen, C Cheng, Y Zhang, Z Liu*., 2017
- Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma., Lin X, Li AM, Li YH, Luo RC, Zou YJ, Liu YY, Liu C, Xie YY, Zuo S, Liu Z, Liu Z*, Fang WY*., 2020
- SPEN induces miR-4652-3p to target HIPK2 in nasopharyngeal carcinoma., Y Li, YM Lv, C Cheng, Y Huang, L Yang, JJ He, XY Tao, YY Hu, YT Ma, Y Su, LY Wu, GF Yu, QP Jiang, S Liu, X Liu, Z Liu*., 2020
Awards
- Guangdong Province Special Support Plan 'Young Top-notch Talent in Scientific and Technological Innovation'
- Guangdong Province Outstanding Young Teacher in Higher Education
- Guangzhou 'Pearl River Science and Technology New Star'
- Guangzhou High-level Talent
- Guangzhou Medical University 'Nanshan Scholar Outstanding Talent'